04/01/2026
Congratulations to Dr. Anil Bidkar on being selected as the recipient of the SNMMI-PCF Young Investigator's Award.
Dr. Bidkar's award supports his proposal to develop a CD46-targeted radiotherapy platform designed to overcome tumor heterogeneity in metastatic castration-resistant prostate cancer, a lethal stage of the disease that is difficult to treat due to its aggressive progression and molecular heterogeneity across metastatic lesions.
The grant is co-sponsored by the SNMMI Mars Shot Fund and the Prostate Cancer Foundation. https://snmmi.org/Web/News/Articles/Anil-Parsram-Bidkar--PhD--Receives-SNMMI-PCF-Young-Investigator-s-Award.aspx
Society of Nuclear Medicine and Molecular Imaging